AP NEWS

Global Human papillomavirus (HPV) Associated Cancer - API Manufacturers, Marketed and Phase III Drugs Landscape 2018 - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

The ‘Human papillomavirus (HPV) Associated Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018’ report provides comprehensive insights about marketed and Phase III products for Human papillomavirus (HPV) Associated Cancer. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Human papillomavirus (HPV) Associated Cancer

Coverage of API manufacturers for Human papillomavirus (HPV) Associated Cancer marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Human papillomavirus (HPV) Associated Cancer

This report provides a comprehensive understanding of the emerging Phase III therapies for Human papillomavirus (HPV) Associated Cancer which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.

Key Topics Covered:

1. Report Introduction

2. Human papillomavirus (HPV) Associated Cancer: Overview

Risk Factors Causes Symptoms Pathophysiology Prognosis Diagnosis Treatment

3. Comparative Analysis of Marketed and Emerging Products

4. Marketed Therapies

Product Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Clinical Trials Regulatory Milestones Product Development Activities United States Europe Historical Global Sales Forecasted Global Sales

5. Emerging Therapies (Phase III)

Product Description Research and Development Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/7v53fz/global_human?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005335/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs,Cervical Cancer Drugs ,Sexual and Reproductive Health Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 06:53 AM/DISC: 12/19/2018 06:53 AM

http://www.businesswire.com/news/home/20181219005335/en

AP RADIO
Update hourly